CYDY — Cytodyn Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapTurnaround

Annual balance sheet for Cytodyn, fiscal year end - May 31st, USD millions except per share, conversion factor applied.

	2020 May 31st	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	14.3	33.9	4.23	2.54	3.11
Net Total Receivables	0	—	—	—	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	36.8	130	28.4	10.8	10.8
Net Property, Plant And Equipment	0.231	0.846	0.609	0.4	0.264
Net Intangible Assets
Other Long Term Assets
Total Assets	50.5	132	29.2	11.3	11.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	44.5	153	123	120	84.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	53	153	124	121	128
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	-2.48	-21	-94.4	-110	-117
Total Liabilities & Shareholders' Equity	50.5	132	29.2	11.3	11.1
Total Common Shares Outstanding
Total Preferred Shares Outstanding